Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index

BACKGROUND: Locoregional recurrence after neoadjuvant chemotherapy for primary breast cancer is associated with poor prognosis. It is essential to identify patients at high risk of locoregional recurrence who may benefit from extended local therapy. Here, we examined the prediction accuracy and clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Laura L., Sommer, Laura, González Silos, Rosa, Lorenzo Bermejo, Justo, von Au, Alexandra, Seitz, Julia, Hennigs, André, Smetanay, Katharina, Golatta, Michael, Heil, Jörg, Schütz, Florian, Sohn, Christof, Schneeweiss, Andreas, Marmé, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355200/
https://www.ncbi.nlm.nih.gov/pubmed/30703111
http://dx.doi.org/10.1371/journal.pone.0211337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355200/
https://www.ncbi.nlm.nih.gov/pubmed/30703111
http://dx.doi.org/10.1371/journal.pone.0211337

Ejemplares similares